Type 2 inflammation in asthma — present in most, absent in many
John V. Fahy(University of California, San Francisco)
Cited by 1,612
Related Papers
Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts
|The Lancet Respiratory Medicine|2024|8
Estimated Ventricular Size, Asthma Severity, and Exacerbations
|CHEST Journal|2019|7
Assessment of ventilation heterogeneity and particle deposition in asthmatics using combined SPECT/CT imaging and computational modeling approaches
|European Journal of Pharmaceutical Sciences|2025|4